Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mucosal Immunol. 2014 Jan;7(1):114-23. doi: 10.1038/mi.2013.29. Epub 2013 May 22.

Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis.

Author information

  • 11] School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia [2] Hunter Medical Research Institute, John Hunter Hospital, New South Wales, Australia.
  • 2Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • 3School of Veterinary Medicine, University College Dublin, Dublin, Ireland.
  • 4Aerpio Therapeutics, Cincinnati, Ohio, USA.

Abstract

Pharmacological stabilization of hypoxia-inducible factor (HIF) through prolyl hydroxylase (PHD) inhibition limits mucosal damage associated with models of murine colitis. However, little is known about how PHD inhibitors (PHDi) influence systemic immune function during mucosal inflammation or the relative importance of immunological changes to mucosal protection. We hypothesized that PHDi enhances systemic innate immune responses to colitis-associated bacteremia. Mice with colitis induced by trinitrobenzene sulfonic acid were treated with AKB-4924, a new HIF-1 isoform-predominant PHDi, and clinical, immunological, and biochemical endpoints were assessed. Administration of AKB-4924 led to significantly reduced weight loss and disease activity compared with vehicle controls. Treated groups were pyrexic but did not become subsequently hypothermic. PHDi treatment augmented epithelial barrier function and led to an approximately 50-fold reduction in serum endotoxin during colitis. AKB-4924 also decreased cytokines involved in pyrogenesis and hypothermia, significantly reducing serum levels of interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α while increasing IL-10. Treatment offered no protection against colitis in epithelial-specific HIF-1α-deficient mice, strongly implicating epithelial HIF-1α as the tissue target for AKB-4924-mediated protection. Taken together, these results indicate that inhibition of prolyl hydroxylase with AKB-4924 enhances innate immunity and identifies that the epithelium is a central site of inflammatory protection afforded by PHDi in murine colitis.

PMID:
23695513
[PubMed - indexed for MEDLINE]
PMCID:
PMC3772994
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk